Innova Vascular, Inc. filed a Form D with the Securities and Exchange Commission on 2025-07-30.
Innova Vascular, Inc. filed a Form D notice of an exempt securities offering with the SEC on July 30, 2025. The filing reports $10M sold. Its industry group is Other Technology. It names Sanjay Shrivastava (Executive Officer, Director), Mike Hennessy (Director), Owen O'Neill (Director) (SEC Form D, July 30, 2025).
Is this your company?
Sell to companies like Innova Vascular, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-07-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Innova Vascular, Inc.
Free to see. No signup.
More on the people and the money behind Innova Vascular, Inc., from the filings we hold.
Other Technology raises by companies based in California, filed in July 2025, largest first.
Get an email when Innova Vascular, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Innova Vascular, Inc. raises, hires or launches. No email unless you switch it on.
Watch Innova Vascular, Inc. →Get the full cited report on Innova Vascular, Inc.
What the filing shows about Innova Vascular, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Innova Vascular, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Innova Vascular, Inc.'s address as 15375 Barranca Pkwy Suite B-101, Irvine, CA 92618.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Innova Vascular, Inc. is a registered filer with the SEC (CIK 2078842) and has filed since 2025-07-28. 4 filings are on record, the latest on 2025-07-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Innova Vascular, Inc.'s Form D of 2025-07-30 names Sanjay Shrivastava, Mike Hennessy and Owen O'Neill as its officers, directors or promoters.
Its new offerings report $21.87M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3842 filings in Other Technology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Innova is engaged in developing innovative medical devices for treating vascular disease using a minimally invasive approach. Contact us.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Sanjay Shrivastava is named as Executive Officer and Director on the Form D that Innova Vascular, Inc. filed with the SEC on 30 July 2025, one of 3 people that filing names.
Mike Hennessy is named as Director on the Form D that Innova Vascular, Inc. filed with the SEC on 30 July 2025, one of 3 people that filing names.
Owen O'Neill is named as Director on the Form D that Innova Vascular, Inc. filed with the SEC on 30 July 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-07-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Innova Vascular, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Innova Vascular, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Innova Vascular, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Innova Vascular, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Innova Vascular, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (innovavascular.com).
Each opens in a new tab, filled in for Innova Vascular, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Los Angeles
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/innova-vascular-inc-form-d-25000004